The AGRN Gene Myasthenic Syndrome Congenital NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with congenital myasthenic syndromes. These syndromes are a group of inherited neuromuscular disorders that can significantly impact muscle function and strength. Understanding your genetic predisposition is crucial for effective management and treatment of these conditions.
The test has a turnaround time of 3 to 4 weeks and requires a blood sample for analysis. Prior to the test, a genetic counseling session is recommended to discuss the clinical history and to create a pedigree chart of affected family members.